The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ID: ALA4172635
Max Phase: Preclinical
Molecular Formula: C11H8Cl2FN3O3S
Molecular Weight: 352.17
Molecule Type: Small molecule
Associated Items:
Representations Canonical SMILES: COc1nc(F)cnc1NS(=O)(=O)c1cccc(Cl)c1Cl
Standard InChI: InChI=1S/C11H8Cl2FN3O3S/c1-20-11-10(15-5-8(14)16-11)17-21(18,19)7-4-2-3-6(12)9(7)13/h2-5H,1H3,(H,15,17)
Standard InChI Key: NWSUDJQTTGDPIR-UHFFFAOYSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Properties Molecular Weight: 352.17Molecular Weight (Monoisotopic): 350.9647AlogP: 2.73#Rotatable Bonds: 4Polar Surface Area: 81.18Molecular Species: ACIDHBA: 5HBD: 1#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0CX Acidic pKa: 5.47CX Basic pKa: CX LogP: 2.80CX LogD: 1.90Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.92Np Likeness Score: -2.00
References 1. Kindon N, Andrews G, Baxter A, Cheshire D, Hemsley P, Johnson T, Liu YZ, McGinnity D, McHale M, Mete A, Reuberson J, Roberts B, Steele J, Teobald B, Unitt J, Vaughan D, Walters I, Stocks MJ.. (2017) Discovery of AZD-2098 and AZD-1678, Two Potent and Bioavailable CCR4 Receptor Antagonists., 8 (9): [PMID:28947948 ] [10.1021/acsmedchemlett.7b00315 ]